Zhao et al., 2007 - Google Patents
Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirusZhao et al., 2007
View PDF- Document ID
- 5180059491258679442
- Author
- Zhao J
- Huang Q
- Wang W
- Zhang Y
- Lv P
- Gao X
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
By using a series of overlapping synthetic peptides covering 98% of the amino acid sequence of the nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus (SARS-CoV), four helper T-cell (Th) epitopes (NP11, residues 11 to 25; NP51 …
- 108090001074 Nucleocapsid Proteins 0 title abstract description 59
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tan et al. | Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers | |
He et al. | Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus | |
Kim et al. | Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus | |
Oostra et al. | Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M | |
Zhang et al. | Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies | |
Tumpey et al. | Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus | |
Woo et al. | Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia | |
De Haan et al. | Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation | |
Llanes et al. | Betacoronavirus genomes: how genomic information has been used to deal with past outbreaks and the COVID-19 pandemic | |
He et al. | Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus | |
Brockway et al. | Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase | |
Zhong et al. | B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein | |
Woo et al. | Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia | |
Zhao et al. | Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus | |
Lam et al. | Loss of orf3b in the circulating SARS-CoV-2 strains | |
Liang et al. | Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice | |
Watanabe et al. | Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein | |
Veit et al. | CD8+ T cells responding to the middle east respiratory syndrome coronavirus nucleocapsid protein delivered by vaccinia virus MVA in mice | |
Lu et al. | Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus | |
Hachim et al. | Beyond the Spike: identification of viral targets of the antibody responses to SARS-CoV-2 in COVID-19 patients | |
De Giuseppe et al. | Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay | |
Bai et al. | Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells | |
Fritzen et al. | Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach | |
Aggarwal et al. | T‐cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus | |
Mordasini et al. | Analysis of the antibody response to an immunodominant epitope of the envelope glycoprotein of a lentivirus and its diagnostic potential |